INSULET CORP — Director's Dealing 2016

Apr 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSULET CORP (PODD)
CIK: 0001145197
Period of Report: 2016-04-01

Reporting Person: Petrovic Shacey (President, Diabetes Products)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-01	Common Stock	F	740	$33.52	Disposed	78782	Direct

Footnotes

F1: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

F2: Includes 37,977 restricted stock units granted on February 9, 2015, which vest one-half of the total units on February 9, 2017 and one-half of the total units on February 9, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 21,360 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.

F3: Includes 712 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on December 31, 2015.